ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400938306996
  • CIP7 3830699
  • CIS 64005832
  • Registration number EU/1/07/430

What the source publishes

Holder
GILEAD SCIENCES IRELAND UC (IRLANDE)
Active ingredients
ÉFAVIRENZ, TÉNOFOVIR DISOPROXIL, EMTRICITABINE, TÉNOFOVIR DISOPROXIL (FUMARATE DE)
Form
comprimé pelliculé
Package
flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant
Routes
orale
Administrative status
cancelled
Supply regime
prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
Marketing status
Arrêt de commercialisation (le médicament n'a plus d'autorisation)
Authorised on
2007-12-13
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400938306996
{
  "cis": "64005832",
  "cip7": "3830699",
  "form": "comprimé pelliculé",
  "name": "ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant",
  "cip13": "3400938306996",
  "holder": "GILEAD SCIENCES IRELAND UC (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "GILEAD SCIENCES IRELAND UC (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2007-12-13",
  "compositions": [
    {
      "name": "ÉFAVIRENZ",
      "nature": "SA",
      "strength": "600 mg",
      "linkageNumber": "1",
      "substanceCode": "17256",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "TÉNOFOVIR DISOPROXIL",
      "nature": "FT",
      "strength": "245 mg",
      "linkageNumber": "3",
      "substanceCode": "29337",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "EMTRICITABINE",
      "nature": "SA",
      "strength": "200 mg",
      "linkageNumber": "2",
      "substanceCode": "60459",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "TÉNOFOVIR DISOPROXIL (FUMARATE DE)",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "3",
      "substanceCode": "89901",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculé",
  "marketingStatus": "Arrêt de commercialisation (le médicament n'a plus d'autorisation)",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec fermeture de sécurité enfant",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2021-12-31",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ÉFAVIRENZ",
    "TÉNOFOVIR DISOPROXIL",
    "EMTRICITABINE",
    "TÉNOFOVIR DISOPROXIL (FUMARATE DE)"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière annuelle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": "EU/1/07/430",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400938306996"